ClinicalTrials.gg
Sign In

Hemolysis clinical trials

The registry lists 120 studies for Hemolysis across more than 10 countries. 22 are recruiting or about to start. 45 of them are mainly about Hemolysis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22.

Get an email when these change. Save the Hemolysis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
66
Recruiting
19
Status unknown
15
Withdrawn
8
Terminated
6
Active, not recruiting
3

Phase

Phase 2
22
Phase 3
11
Phase 1
8
Phase 4
6
Early Phase 1
2

Where

United States
36
France
15
Italy
10
Canada
9
United Kingdom
9
Spain
8

Who runs them

Alexion Pharmaceuticals, Inc. (6) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Hospices Civils de Lyon (3) · Assistance Publique - Hôpitaux de Paris (3) · Novartis Pharmaceuticals (3) · Apellis Pharmaceuticals, Inc. (3) · Cairo University (2)

What is being tested here

Drugs under test in Hemolysis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Danicopan133
Ravulizumab101
Voxelotor101
Rituximab024
Eculizumab023
Pegcetacoplan003
Ribavirin003
Etavopivat012
Iptacopan002
Acetaminophen012

Coming up

3phase 3 studies under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 19 Hemolysis studies recruiting now, 6 (32%) set no upper age limit and 9 (47%) stop at 75 or younger. 6 (32%) take children under 18. 3 (16%) are for women only and 0 (0%) for men only; 1 (5%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
103 (16%)3 (16%)
1812 (63%)10 (53%)
3012 (63%)10 (53%)
4014 (74%)11 (58%)
5012 (63%)11 (58%)
6512 (63%)12 (63%)
7510 (53%)10 (53%)
8510 (53%)10 (53%)

Across all 120 studies, recruiting or not: 30% stop at 75 or younger and 25% at 65; 36% take children; 3% are for women only and 2% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hemolysis studies take

Of 28 interventional studies with no phase under Hemolysis, half reached primary completion within 11 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase11 mo3–35 · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 120. Browse all 120 → or search them.